Welcome to our dedicated page for Petmed Express news (Ticker: PETS), a resource for investors and traders seeking the latest updates and insights on Petmed Express stock.
PetMed Express Inc (PETS), America's largest online pet pharmacy, provides this centralized hub for official corporate communications and market-moving developments. Access verified press releases, SEC filings, and strategic announcements from the nation's leading direct-to-consumer pet medication provider.
Investors and industry observers will find comprehensive coverage of financial results, regulatory updates, product innovations, and partnership agreements. Our curated news feed tracks material events impacting PETS' position in the $100B pet healthcare market, including prescription medication approvals and e-commerce platform enhancements.
Key updates include quarterly earnings disclosures, FDA compliance announcements, and distribution network expansions. All content is sourced directly from company filings and official statements to ensure regulatory compliance and factual accuracy.
Bookmark this page for real-time access to PETS' corporate communications, including 8-K filings detailing material events and 10-K annual reports. Check regularly for updates on the company's mission to deliver affordable pet healthcare through its innovative online pharmacy model.
PetMed Express (NASDAQ: PETS) announced significant leadership changes as CEO Sandra Campos and CFO Robyn D'Elia have resigned from their positions. Board Chair Leslie C.G. Campbell has been appointed as Interim CEO, while Chief Accounting Officer Douglas Krulik will serve as Interim Principal Financial Officer.
The departing executives will receive 13 months of base salary continuation and accelerated vesting of certain restricted stock units as severance, along with providing consulting services for three months. The company has initiated a search for permanent CEO and CFO positions. The Board has been restructured with Justin Mennen appointed as Lead Independent Director, while Peter Batushansky and Leah Solivan will chair the Audit and Compensation committees respectively.
PetMeds (NASDAQ: PETS) has partnered with myBalto Foundation for their "Top of the Class" fundraising drive, successfully raising nearly $45,000 to help pet owners cover emergency veterinary costs. The initiative aims to support myBalto's Angel Fund program, which assists veterinary hospitals in providing financial aid to pet parents facing hardships.
As part of the partnership, PetMeds offered 25% discounts to donors to encourage community participation. The myBalto Foundation provides veterinary hospitals with free Angel Funds, eliminating administrative burdens while enabling quick financial support for pet owners during emergency situations.
PetMed Express (NASDAQ: PETS) has received a notification from Nasdaq on July 2, 2025, regarding non-compliance with listing rules due to delayed filing of its Annual Report on Form 10-K for the fiscal year ended March 31, 2025.
The company has until September 1, 2025 to submit a compliance plan to Nasdaq, which may grant an extension until December 29, 2025 to regain compliance. PetMeds previously filed a Form 12b-25 on June 16, 2025, citing the need for additional time to compile and analyze financial information. The notice has no immediate impact on the company's Nasdaq listing status.
PetMed Express (NASDAQ: PETS), operating as PetMeds and parent company of PetCareRx, announced it will be unable to file its Form 10-K for FY 2025 within the extension period ending July 1, 2025. The delay is due to an ongoing investigation initiated by the Audit Committee following anonymous whistleblower reports.
The whistleblower complaints concern three main issues: revenue recognition timing for certain autoship orders in Q4 2025 that led to customer complaints, a $50 coupon promotion's impact on new customer KPIs, and concerns about the company's culture and control environment. The Audit Committee has engaged external legal counsel and advisors to investigate these matters.
Despite the ongoing investigation, PetMed Express states that based on current evidence, they do not expect the investigation to materially impact their previously announced preliminary Q4 and FY 2025 financial results or previously filed financial statements.
[ "Company does not expect material impact on previously announced financial results", "External legal counsel and advisors engaged for thorough investigation", "Company has established whistleblower reporting system in place" ]PetMed Express (NASDAQ: PETS) has announced a strategic partnership with Wagmo, a pet healthcare benefits provider. Through this collaboration, Wagmo members will receive exclusive benefits, including a $25 credit for new PetMeds accounts.
The partnership enhances Wagmo's Perks Program by providing members with access to discounted pet health products, including medications, supplements, nutritional foods, and daily care essentials for dogs and cats. This initiative aims to make comprehensive pet healthcare more accessible and affordable for employees through workplace benefits.
PetMed Express (NASDAQ: PETS), the parent company of PetCareRx, has scheduled its fourth quarter and full fiscal year 2025 earnings conference call for Tuesday, June 10, 2025, at 4:30 PM Eastern Time. The company will release its financial results for the period ended March 31, 2025, before the call.
The management team will host the call followed by a Q&A session. Investors can join via U.S. dial-in (877-407-0789) or international number (201-689-8562). A replay will be available until June 24, 2025, accessible through toll-free (844-512-2921) or international (412-317-6671) numbers using passcode 13753433.
PetMed Express (NASDAQ: PETS) has announced a strategic partnership with Dutch, a virtual veterinary care provider, to expand accessible telehealth services for pets. Through this collaboration, pet parents can access Dutch's virtual veterinary team for 24/7 appointments in 34 states via a monthly membership program. Dutch's platform has completed nearly 700,000 visits and offers treatment for over 150 conditions.
The partnership aims to address the nationwide veterinarian shortage affecting 129 million Americans (38% of the population) who live in vet-care "deserts." Dutch's virtual care platform will integrate with PetMeds' medication services, enabling pet parents to obtain prescriptions efficiently while ensuring professional veterinary guidance remains central to pet healthcare.
PetMed Express (NASDAQ: PETS) is set to ring the Nasdaq Opening Bell on April 11, 2025, in celebration of National Pet Day. The ceremony will feature adoptable rescue dogs from Bidawee, one of the nation's oldest no-kill animal welfare organizations.
Sandra Campos, President & CEO of PetMeds and PetCareRx®, who personally owns three rescue dogs, nine rescue horses, and a senior cat, emphasized the company's commitment to accessible, preventative pet healthcare. The event highlights PetMeds' support for rescue efforts nationwide through their integrated platform, which provides:
- Prescription medications
- Vet-recommended food and supplies
- Trusted guidance and science-backed solutions
Pet lovers are encouraged to participate by sharing their rescue stories on social media using #PawsontheBell and tagging @PetMeds.
FAQ
What is the current stock price of Petmed Express (PETS)?
What is the market cap of Petmed Express (PETS)?
